Hepatitis C virus is stigmatised because of its association with injecting drug use. Although treatment is available, uptake remains low, especially among people who inject drugs. Ninety health workers completed a survey assessing attitudes towards people who inject drugs and support for treatment for three client scenarios: one who stopped injecting, one on methadone, and one continuing to inject. Support for hepatitis C virus treatment was significantly higher, where the client was not injecting. Participants who showed more negative attitudes towards people who inject drugs were less supportive of clients entering hepatitis C virus treatment, illustrating the influence of health workers’ attitudes in determining treatment options offered to clients.
AspinallEJCorsonSDoyleJS. (2013) Treatment of hepatitis C virus infection among people who are actively injecting drugs: A systematic review and meta-analysis. Clinical Infectious Diseases57(Suppl. 2): S80–S89.
4.
Australian Government Department of Health and Aged Care (2001) Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Canberra, ACT, Australia: Department of Health and Aged Care and Medicare Australia, Pharmaceutical Benefits Scheme.
5.
BrenerLvon HippelWKippaxS (2007) Health care workers and discrimination towards injecting drug users with hepatitis C: Does greater contact lead to less prejudice. International Journal of Drug Policy18: 381–387.
6.
Brener Lvon HippelW (2008) Measuring attitudes toward injecting drug users and people with hepatitis C. Substance Use & Misuse43: 295–302.
7.
BrenerLvon HippelWvon HippelC. (2010) Perceptions of discriminatory treatment by staff as predictors of drug treatment completion: Utility of a mixed methods approach. Drug and Alcohol Review29(5): 491–497.
8.
ButtG (2008) Stigma in the context of hepatitis C: Concept analysis. Journal of Advanced Nursing62(6): 712–724.
9.
CaseyLCLeeWM (2013) Hepatitis C virus therapy update 2013. Current Opinion in Gastroenterology29(3): 243–249.
10.
DimovaRBZeremskiMJacobsonIM. (2013) Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical Infectious Diseases56(6): 806–816.
11.
DoreGJ (2012) The changing therapeutic landscape for hepatitis C (Review). Medical Journal of Australia196(10): 629–632.
12.
EdwardsK (1990) The interplay of affect and cognition in attitude formation and change. Journal of Personality and Social Psychology59(2): 202–216.
13.
EdwardsKvon HippelW (1995) Hearts and minds: The priority of affective versus cognitive factors in person perception. Personality and Social Psychology Bulletin21(10): 996–1011.
14.
FabrigarLRPettyRE (1999) The role of affective and cognitive biases of attitudes in susceptibility to affectively and cognitively based persuasion. Personality and Social Psychology Bulletin15(3): 363–381.
15.
GrebelyJDoreG (2011) What is killing people with hepatitis C virus infection?Seminars in Liver Disease31(4): 331–339.
16.
GrebelyJBryantJHullP. (2011) Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia. Journal of Viral Hepatitis18: 104–116.
17.
GiddensADuneierMAppelbaumRPCarrD (2009) Introduction to sociology (7th ed.). New York: Norton & Company, Inc.
18.
GilmoreN (1996) Drug use and human rights: privacy, vulnerability, disability, and human rights infringements. Journal of Contemporary Health Law Policy12: 355–337.
19.
GoffmanE (1963) Notes on the management of spoiled identity. Upper Saddle River, NJ: Prentice-Hall.
20.
HeblMRFosterJBMannixLM. (2002) Formal and interpersonal discrimination: A field study of bias toward homosexual applicants. Personality and Social Psychology Bulletin28(6): 815–825.
21.
HopwoodMTreloarC (2013) Under the watchful eye of a ‘benevolent dictator’: General practitioner and patient experiences of hepatitis C treatment initiation. Australian Family Physician42: 900–903.
22.
HopwoodMLeaTAggletonP (2016) Multiple strategies are required to address the information and support needs of gay and bisexual men with hepatitis C in Australia. Journal of Public Health38(1): 156–162.
23.
HopwoodMTreloarCBryantJ (2006) Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs: Education, Prevention & Policy13(1): 61–75.
24.
IversenJGrebelyJToppL. (2014) Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999–2011. Journal of Viral Hepatitis21(3): 198–207.
25.
Kirby Institute (2014) HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2014. Sydney, NSW, Australia: Kirby Institute, UNSW Australia.
26.
LawMGDoreGJBathN. (2003) Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology32(5): 717–724.
27.
Munoz-PlazaCEStraussSAstone-TwerellJ. (2008) Exploring drug users’ attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S. International Journal of Drug Policy19(1): 71–78.
28.
NelsonPMathersBCowieB. (2011) Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. The Lancet378: 571–583.
29.
PascoeEASmart RichmanL (2009) Perceived discrimination and health: a meta-analytic review. Psychological Bulletin135: 531–554.
30.
PatersonBBackmundMHirschG. (2007) The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy18: 364–373.
31.
RazaliKAminJDoreG.; The HCV Projections Working Group (2009) Modelling and calibration of the hepatitis C epidemic in Australia. Statistical Methods in Medical Research18(3): 253–270.
32.
SabinJNosekBGreenwaldA. (2009) Physicians explicit and implicit attitudes about race by MD race, ethnicity and gender. Journal of Health Care for the Poor and Underserved20(3): 869–913.
33.
TreloarCNewlandJRanceJ. (2010) Uptake and delivery of hepatitis C treatment in opiate substitution treatment: Perceptions of clients and health professionals. Journal of Viral Hepatitis17: 839–844.
34.
TreloarCRanceJBackmundM (2013) Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases57: S51–S55.
35.
WilsonHBrenerLMaoL. (2014) Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia. Drug and Alcohol Dependence144: 274–278.
36.
YoungMStuberJAhern. (2005) Interpersonal discrimination and the health of illicit drug users. The American Journal of Drug and Alcohol Abuse31(3): 371–391.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
